Remove Hormones Remove Insulin Remove Medicine
article thumbnail

(LAI-287 + semaglutide) by Novo Nordisk for Type 2 Diabetes: Likelihood of Approval

Pharmaceutical Technology

(LAI-287 + semaglutide) overview A fixed dose combination of GLP-1 analogue semaglutide and LAI-287, long-acting basal insulin is under development for the treatment of type 2 diabetes. The drug candidate is administered as an subcutaneous formulation.The combination acts by targeting GLP-1R and insulin receptor.

Insulin 182
article thumbnail

Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approval

pharmaphorum

GLP-1 and GIP are hormones involved in blood sugar control and Mounjaro, a first-in-class medicine that activates both GLP-1 and GIP receptors, demonstrated improved blood sugar control. It was also compared to a placebo, a GLP-1 receptor agonist (semaglutide) and two long-acting insulin analogues. more than insulin glargine.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA approves Lyumjev® (insulin lispro-aabc injection) 100 units/mL for use in insulin pumps

The Pharma Data

approval of pump use for Lilly’s novel insulin is latest development designed to help people with diabetes manage blood sugar levels. Lyumjev, a novel formulation of insulin lispro developed to speed the absorption of insulin into the bloodstream and reduce A1C levels, was approved by the FDA in June 2020.

Insulin 52
article thumbnail

Lilly again reduces list price of Insulin Lispro Injection as latest change to affordability options

The Pharma Data

Lilly’s Insulin Lispro Injection, 100 units/mL — first introduced at half the list price of branded Humalog® (insulin lispro injection, 100 units/mL) in 2019 — will now have a 70 percent lower list price than Humalog U-100 starting January 1, 2022 Insulin Lispro Injection can be ordered through all U.S.

Insulin 52
article thumbnail

COVID-19 May Trigger New-Onset Diabetes

XTalks

A report published in the New England Journal of Medicine (NEJM) in August 2020 — followed by several more studies, including one in Diabetes, Obesity and Metabolism in November — reported on the observed link. Experts are unclear as to why the phenomenon is occurring among some patients.

Insulin 105
article thumbnail

Novo Nordisk to buy Emisphere and diabetes pill tech for $1.8bn

pharmaphorum

billion, as it continues its quest to develop diabetes medicines that can be taken as pills. But the company has tried and failed to produce insulin that can be taken orally – this proved unfeasible due to the high doses of the hormone that were needed for absorption through the gut.

Insulin 111
article thumbnail

Biologic Therapeutics Development, Part 1: Definition and Distinct Characteristics

Camargo

The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available. Biologics include a wide range of products , including: Vaccines. Blood and blood components. Allergenics. Somatic cells.